Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardium Therapeutics
Cardium Completes Registered Direct Investment
August 9th, 2008
Cardium Therapeutics (AMEX:CXM) announced that it has completed a registered direct offering with accredited investors for the purchase of shares of its common stock and warrants to purchase additional shares of its common stock. The transaction resulted in gross proceeds to Cardium of approximately $3.34 million, before placement agent fees and offering expenses and excluding any future proceeds from the exercise of the warrants issued in the offering. Cardium intends to use the proceeds for general working capital purposes. Empire Asset Management Company acted as financial advisor and the sole placement agent for the transaction. The securities were offered pursuant...
Source: Law & Health Weekly (2008-08-09)
|
